<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="editorial" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Chem.</journal-id>
<journal-title>Frontiers in Chemistry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Chem.</abbrev-journal-title>
<issn pub-type="epub">2296-2646</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">754294</article-id>
<article-id pub-id-type="doi">10.3389/fchem.2021.754294</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Chemistry</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Development and Applications of New Activity-Based Probes</article-title>
<alt-title alt-title-type="left-running-head">Blum et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Editorial: Activity-Based Probe Development</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Blum</surname>
<given-names>Galia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/954594/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Verhelst</surname>
<given-names>Steven H. L.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/126688/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ma</surname>
<given-names>Xiaowei</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/954686/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<label>
<sup>1</sup>
</label>The Faculty of Medicine, The School of Pharmacy, The Institute for Drug Research, The Hebrew University of Jerusalem, <addr-line>Jerusalem</addr-line>, <country>Israel</country>
</aff>
<aff id="aff2">
<label>
<sup>2</sup>
</label>The Wohl Institute for Translational Medicine, The Goldyne Savad Institute for Gene Therapy, Hadassah Hebrew University Medical Center, <addr-line>Jerusalem</addr-line>, <country>Israel</country>
</aff>
<aff id="aff3">
<label>
<sup>3</sup>
</label>KU Leuven, Department of Cellular and Molecular Medicine, <addr-line>Leuven</addr-line>, <country>Belgium</country>
</aff>
<aff id="aff4">
<label>
<sup>4</sup>
</label>Leibniz Institute for Analytical Sciences ISAS, <addr-line>Dortmund</addr-line>, <country>Germany</country>
</aff>
<aff id="aff5">
<label>
<sup>5</sup>
</label>Department of Nuclear Medicine, The Second Xiangya Hospital, Central South University, <addr-line>Changsha</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited and Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/22879/overview">John D. Wade</ext-link>, University of Melbourne, Australia</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Galia Blum, <email>galiabl@ekmd.huji.ac.il</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Chemical Biology, a section of the journal Frontiers in Chemistry</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>09</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>9</volume>
<elocation-id>754294</elocation-id>
<history>
<date date-type="received">
<day>06</day>
<month>08</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>08</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Blum, Verhelst and Ma.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Blum, Verhelst and Ma</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/researchtopic/13869" ext-link-type="uri">Editorial on the Research Topic<article-title>Development and Applications of New Activity-Based Probes</article-title>
</related-article>
<kwd-group>
<kwd>protease probes</kwd>
<kwd>activity-based probe</kwd>
<kwd>recognition element</kwd>
<kwd>ABP generation</kwd>
<kwd>ABP application</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Tools that detect the activity of enzymes can be utilized in several ways: for studying enzyme involvement in both healthy and pathological conditions, for imaging applications, as diagnostic reagents and for screening of new drug leads. Activity-based probes (ABPs) are a class of chemical tools that bind to active enzymes and report on their activity. In contrast to substrate reporters, ABPs covalently attach to their active enzyme target and covalently link a reporter to it. The covalent modification enables studying the fraction of active enzyme in systems such as purified enzymes, cell lysates, intact cells and even whole animals. The enzyme&#x2013;ABP complex can be detected using several methods including microscopy, fluorescent activated cell sorting (FACS), gel analysis, <italic>in vivo</italic> imaging, or by mass spectrometry.</p>
<p>Although the above applications are highly informative and extremely useful, they are usually applied in a low throughput manner. In this special issue of Frontiers, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2021.640105%20">Jones et&#x20;al.</ext-link> have elegantly described methods for high-throughput ABPP (ABPP-HT) using a pan deubiquitylating enzyme (DUB) targeted probe for proof of concept. Their methodology, which combines short chromatography gradients and fast scan speeds (using Parallel Accumulation Serial Fragmentation (PASEF) data acquisition), allows increased sample throughput in a microplate format and rapid analysis of up to 300 samples per day. The authors were able to efficiently analyze a few inhibitors on a panel of 30&#x2013;40 DUBs in two cell lines and mouse brain lysate. These novel methodologies bring the use of ABPs a big leap forward in the attempt to study the activity of proteases in a complex proteome.</p>
<p>One of the biggest challenges in the field of ABPs is developing selective probes that detect a single enzyme. The underlying reason is close substrate specificity between related enzymes. Selective ABPs are difficult to generate, even using positional scanning libraries. Recently, new approaches have been brought to the protease field, such as hybrid combinatorial substrate libraries (HyCoSuL) that uses unnatural amino acids in a substrate library (<xref ref-type="bibr" rid="B2">Poreba et&#x20;al., 2014</xref>) and phage display (<xref ref-type="bibr" rid="B1">Chen et&#x20;al., 2021</xref>). Nevertheless, pan-selective probes that label a subset of enzymes have their own advantages: they usually produce stronger signals than selective probes, thus enabling easier detection. In addition, the activity of specific enzymes can be analyzed biochemically, for example by gel-based methods, enabling the monitoring of differences in activity of a group of enzymes at once. The application of selective probes in comparison with a pan-protease probes is nicely demonstrated in the work of <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2020.628433%20">van Dalen et&#x20;al.</ext-link> who generated a selective cathepsin S ABP with help of docking experiments. After probe generation and evaluation, it was applied to study cathepsin S activity in bone marrow derived macrophage cells treated with <italic>E. Coli</italic>. Images were generated using confocal and correlative light-electron microscopy imaging showing vesicles that contain active cathepsin S but no other cathepsins.</p>
<p>While most ABPs include recognition-elements derived from peptides/proteins (including natural or non-natural amino acids), this issue of Frontiers includes two manuscripts describing ABPs based on inhibitors (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2021.640566%20">Van Rymenant et&#x20;al.</ext-link>); (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2021.642273">Keuler et&#x20;al.</ext-link>). <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2021.640566%20">Van Rymenant et&#x20;al.</ext-link> describe probes selective towards Fibroblast activation protein (FAP) and <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2021.642273">Keuler et&#x20;al.</ext-link> describe their success in generating inhibitor based ABPs targeted to NLRP3. The FAP probes were evaluated on recombinant enzymes and cell lysates, and they were useful in monitoring FAP activity in transfected intact cells as well as in urothelial cancer tissue sections (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2021.640566%20">Van Rymenant et&#x20;al.</ext-link>). The NLRP3 probes were evaluated for their target binding, influence on bone marrow-derived macrophages viability, cytokine secretion and ability to detect NLRP3 in cells by microscopy (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2021.642273">Keuler et&#x20;al.</ext-link>). The activity of both these important targets can now be studied using ABP methodology.</p>
<p>An interesting review by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2021.644811">Van der Zouwen et&#x20;al.</ext-link> nicely describes several methodologies for generating libraries of ABPs, opposed to conventional synthetic methods that generate individual probes one at a time. Modular probe synthesis and probe modifications were described including DNA-encoded libraries, phage display, multicomponent reactions (MCR), Sulfur (VI) &#xfb02;uoride exchange (SuFEx) click chemistry, cyclization and trifunctional reagents, all to generate versatile probes. The advancements in probe generation indeed open ample opportunities for directing novel probes to new targets using novel applications.</p>
<p>A review by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2021.628295">Burster et&#x20;al.</ext-link> describes the development and use of a variety of ABPs including quenched probes, CyTOF labeled probes, fluorescent and radioactive probes. They then focus on cathepsin G probes and describe their application in studying intracellular and extracellular activity. In addition, a review by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2021.639410">Kasperkiewicz</ext-link> methodically goes through the components of ABPs and discusses each in depth, the history, advantages and disadvantages and their incorporation within serine ABPs. A nice comparison is made between substrates probes and ABPs describing their use and limitations. The generation and choice of tag, recognition element and electrophile are discussed as well as the application of serine ABPs to various systems. The Kasperkiewicz review is a thorough overview on serine ABPs that share ample details on specific probes targeted to serine proteases, with a focus on human neutrophil elastase, cathepsin G and Kallikreins.</p>
<p>In conclusion, this special edition of Frontiers in Chemistry Chemical Biology gives a broad and in-depth- overview on ABPs, their generation and applications. It also describes various new ABPs and novel applications for a variety of proteases.</p>
</body>
<back>
<sec id="s1">
<title>Author Contributions</title>
<p>All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.</p>
</sec>
<sec sec-type="COI-statement" id="s2">
<title>Conflict of Interest</title>
<p>The authors declare no commercial or financial relationship that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s3" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lovell</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fellner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mace</surname>
<given-names>P. D.</given-names>
</name>
<name>
<surname>Bogyo</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Identification of Highly Selective Covalent Inhibitors by Phage Display</article-title>. <source>Nat. Biotechnol.</source> <volume>39</volume> (<issue>4</issue>), <fpage>490</fpage>&#x2013;<lpage>498</lpage>. <pub-id pub-id-type="doi">10.1038/s41587-020-0733-7</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poreba</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kasperkiewicz</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Snipas</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Fasci</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Salvesen</surname>
<given-names>G. S.</given-names>
</name>
<name>
<surname>Drag</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Unnatural Amino Acids Increase Sensitivity and Provide for the Design of Highly Selective Caspase Substrates</article-title>. <source>Cell Death Differ</source> <volume>21</volume> (<issue>9</issue>), <fpage>1482</fpage>&#x2013;<lpage>1492</lpage>. <pub-id pub-id-type="doi">10.1038/cdd.2014.64</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>